Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

NCT02557100 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Abatacept
DRUG: Adalimumab
DRUG: Methotrexate

Sponsor

Bristol-Myers Squibb